Although we have so far identified and sequenced >2000 human long cDNAs, known as KIAA cDNAs, half of them have yet to be functionally annotated. Expression-ready cDNA clones derived from these genes, where the open reading frame (ORF) of the gene of interest is placed under the control of an appropriate promoter, are critical for functional characterization of these gene products. In this study, we attempted to systematically convert original cDNA clones to expression-ready forms for native and fusion proteins. For this purpose, we developed a new method for ORF cloning based on a homologous recombination in Escherichia coli to avoid laborious manipulations and artificial introduction of mutations in ORF. Using 1589 putative full-length ORFs (from 1002 KIAA genes, 119 human known genes and 468 mouse genes) with an average size of 2.8 kb, we successfully prepared expression plasmids for 1463 native proteins and for 1343 fusion proteins by this method. The resultant expression-ready clones were examined using an in vitro transcription/translation system followed by SDS-polyacrylamide gel electrophoresis and by transient expression of GFP-fusion proteins in human embryonic kidney (HEK) 293 cells. This set of expressionready clones of long cDNAs encoding large proteins would open a new route to experimentally analyze their functions on a proteomic scale, since unavailability of expression-ready clones for mammalian large proteins has been a major obstacle to the functional analysis of these cDNAs.
Introduction
In the last decade, whole genome sequences have been revealed from bacteria to humans in a complete or a draft form. This invaluable information is expected to shift the paradigm of molecular biology by making it possible to predict a complete catalog of protein-coding genes in an organism. However, the genome sequence information alone is not sufficient to achieve this. Information about transcribed sequences is indispensable for deducing protein primary structures encoded by the mammalian genome due to difficult-to-predict exon-intron structure.
Furthermore, because the protein primary structures do not necessarily enable us to deduce their biological functions, we need various types of genomic resources to experimentally explore them in a genome-wide manner. In particular, a set of expression plasmids for all the proteins in an organism serves as an indispensable reagent for functional genomics. Thus, many efforts have been made to prepare sets of defined protein-expression clones, so-called 'ORFeome cloning', to analyze protein function on a proteomic scale. [1] [2] [3] [4] [5] [6] [7] Although open reading frame (ORF) is different from the protein-coding sequence (CDS) by definition, we hereafter use ORF rather than CDS for protein-coding sequence to avoid unnecessary confusion, contrary to the conventions used by other researchers.
Although ORF cloning into expression vectors has already been attempted in mammals, 6, [8] [9] [10] it involves many technical difficulties at the ORFeome level. The most serious problem is the difficulty in predicting the ORFeome from the mammalian genomic information. Thus, to achieve reliable prediction of protein-coding genes, a large volume of sequence information of cDNAs was accumulated to complement the genomic sequence information in the public domain. [11] [12] [13] [14] [15] [16] [17] [18] Furthermore, rapidly growing data of genomic and transcriptomic sequences from several different mammals allow us to make comparisons and thereby assign mammalian ORFeomes more convincingly than was possible a few years ago. Therefore, we believe that ORFeome cloning in mammals is a research area that should be accorded high priority.
Our cDNA sequencing project was unique, focusing on long cDNAs (>4 kb) encoding relatively large proteins from the brain. This was because of our interest in cDNA clones encoding multidomain proteins, many of which play crucial roles, such as signal transduction, cell-cell communication, cell structure/motility and gene regulation, in multicellular organisms. 19, 20 More than 2000 newly isolated cDNAs have been entirely sequenced (referred to as KIAA plus a 4-digit number; the average number of amino acid residues in KIAA ORFs was 949). The KIAA cDNA sequences and clones are continuously updated if their ORFs were spuriously interrupted or truncated. 21 We have recently started to collect cDNA clones for mouse homologs of human KIAA (mKIAA) genes and polyclonal antibodies against mKIAA proteins to explore the function of KIAA gene products using an animal model in vivo. 17, [22] [23] [24] The information about KIAA and mKIAA genes is available through our databases (HUGE for human KIAA genes; http://www.kazusa.or.jp/huge and ROUGE for mouse KIAA genes; http://www.kazusa.or.jp/rouge). 25 Approximately half of the KIAA proteins have not been functionally annotated by Gene Ontology. 26 To overcome this situation, it is essential to express KIAA proteins in cells and analyze their functions. Thus, we considered that preparation of cDNA clones in an expressionready format to accelerate the functional study of KIAA gene products with unknown function on a molecular level was urgently needed. A set of KIAA ORF clones would constitute an indispensable subset of the human ORFeome collection. To achieve this, we needed to solve some technical problems in transferring long ORF to an expression vector in a systematic manner. In this study, we developed a new method, termed as the ORF trap method, for ORFeome cloning of long cDNAs. We describe the details of the ORF trap method, its application to long ORF cloning, and characterization of the protein products of the resultant ORF clones. The results indicate that this method worked effectively and the resultant clone set could be successfully used as a versatile reagent for functional characterization of large proteins.
Materials and Methods

Materials
pTRAP1 plasmid DNA was constructed by the Gateway BP reaction with pDONR201 plasmid (Invitrogen, USA) and the attB1-SD-Kozak-Not I-attB2 fragment (5 0 -GGGGACAAGTTTGTACAAAAAAGC-AGGCTTCGAAGGAGATAGAACCATGGGGGATG-TGAAGCTGGTTGCCTCGTCACACATTTCCAAA-ACCTCCCTCAGTGTGGCGGCCGCCTCATTGTG-GAAACGATGGAGGAAGGTGAAGGGGAAGGGG-AAGAGGAAGAAGAGTGGAACCCAGCTTTCTT-GTACAAAGTGGTCCCC-3 0 ) according to the instructions provided by the supplier, followed by insertion of the DNA fragment harboring the chloramphenicol resistance and ccdB genes amplified by PCR with pDONR201 into the NotI site. The expression clones including various ORFs were constructed by the Gateway LR reaction with the entry clones amplified by the TempliPhi Amplification Kit (Amersham Biosciences, UK) and pcDNA-DEST47 for expression in an in vitro transcription/translation system or in mammalian cells.
Cultured cells
The human embryonic kidney (HEK) 293 cell line was obtained from the Health Science Research Resources Bank (HSRRB) of the Japan Health Sciences Foundation. The cell line was grown in DMEM supplemented with 10% of Tet System Approved Fetal Bovine Serum (BD Biosciences, USA).
2.3. Preparation of JC8679 competent cells for electroporation E. coli strain JC8679 (recB21, recC22, sbcA23, thr-1, leuB6, phi-1, lacY1, galK2, ara-14, Xyl-5, mtl-1, proA2, his-4, argE3, rpsL31, tsx-33, supE44, his-328) was obtained from HSRRB of Japan Health Sciences Foundation and used for bacterial transformation. The competent bacterial cells were prepared as follows: a single colony of JC8679 was picked and grown in 30 ml of SOB medium overnight at 37 C. After 5 ml of the cultured bacteria were inoculated into 500 ml of SOB medium, they were cultured with agitation at 37 C until the cells reached OD 600 ¼ 0.35-0.4. The cells were then chilled on ice for 15 min and harvested by centrifuging of 2300 g for 10 min at 2 C. After discarding the supernatants, the cells were suspended in 5 ml of ice-cold H 2 O, then 500 ml of ice-cold H 2 O was added and the cells were centrifuged and then washed twice. After washing with 20 ml of ice-cold 10% glycerol, the cells were suspended in 1.25 ml of ice-cold 10% glycerol. Finally, the cells were divided and placed in separate tubes, frozen in dry iceethanol and stored in À80 C freezer.
Homologous recombination
A linear plasmid containing gene-specific sequences was generated by PCR in a 50 ml reaction including 2.5 units LA Taq DNA polymerase (Takara, Japan), 0. 25 The transformed cells were incubated in 500 ml of SOC at 37 C for 2 h with agitation and were plated on LB-kanamycin (50 mg/ml) agar. To select recombinant clones, plasmid DNAs were prepared from at least eight colonies per electroporation by the nucleic acid purification system, MFX-9600-Magnia with MagExtractor (Toyobo, Japan) in a 96-well format and the recombined regions were confirmed by single-pass sequencing. Single-pass sequencing was performed from both ends of the insert DNA with GatewaySeqL-A (
0 ) primers and ABI BigDye Terminator Cycle Sequencing Kit Ver. 3.1 (Applied Biosystems, USA) using ABI3700 DNA sequencer. After arraying the plasmid clones correctly recombined in a new 96-well plate, the plasmid DNAs were introduced into competent DH10B cells to resolve plasmid multimers formed in JC8679 and were amplified. At the same time, singlepass sequencing was performed from both ends of the insert DNA again and the sizes of the plasmid DNAs in a covalently closed circular form were estimated by agarose gel electrophoresis with a molecular weight marker for supercoiled DNA (Supercoiled DNA Ladder, Invitrogen, USA) followed by an ethidium bromide-staining and the FragmeNT analysis of gel image data obtained by FluorImager SI (Molecular Dynamics, USA). Although most of the original clones whose backbones were pBluescript II SK (þ) vector were adapted into linear form, the cDNA fragment cloned in the pSPORT1 vector were cut out with appropriate restriction enzymes before the recombination reaction to prevent undesired recombination. For some cDNA clones with truncation of a few amino acid residues at the predicted N-terminal sequence, entry clones were constructed by using genespecific primers containing complementing sequences to make full-length ORFs.
In vitro transcription/translation assay
pcDNA-DEST47 destination vector (Invitrogen, USA) was used for the Gateway LR reaction with the entry clones we constructed to produce proteins by an in vitro transcription/translation system using rabbit reticulocyte lysate. For the fusion type of expression clones, C-terminal Cycle 3 green fluorescent protein (GFP)-fusion vector was used. Plasmid DNAs used in an in vitro expression were prepared by MFX-9600-Magnia in a 96-well format from overnight-cultured bacteria and were purified using MultiScreen, MAFB NOB (Millipore, USA) according to the instructions provided by the manufacturer. Plasmids (100-200 ng) were subjected to an in vitro transcription/translation system (TNT T7 Quick Coupled Reticulocyte Lysate System, Promega, USA) in the presence of 4 ml of Quick Mix, 0.2 ml of FluoroTect TM Green Lys tRNA (Promega, USA) and 0.1 ml of 1 M methionine in a final reaction volume of 5.3 ml. The products were resolved on MDG-267 Real Gel Plate (concentration gradient: 5-10%, Biocraft, Japan). Prestained protein size markers (BenchMark size markers, Invitrogen, USA) were used for estimation of the apparent molecular masses of the in vitro products. When multiple discrete bands were observed from a single clone, the size of the largest band was estimated.
Subcellular localization of GFP-fusion protein
GFP-fusion protein expression clones used for subcellular localization were constructed and prepared as described above. Resultant purified DNAs (100-200 ng) were transfected into HEK293 cells using FUGENE 6 Transfection Reagent (Roche, USA) in an 8-well chambered coverglass (Nalge Nunc International, USA). Cells (200 ml; 4 · 10 4 ) were plated 24 h before the transfection experiment. After 40-50 h of transfection, the subcellular localization of the GFP-fusion proteins was observed by fluorescent microscope (Axiovert S100, Zeiss, Germany) and recorded (DP70, Olympus, Tokyo).
Western blotting
For western blot analysis of GFP-fusion proteins, expression clones were constructed as described above
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and prepared using QIAGEN Plasmid Kit (Qiagen, Germany). HEK293 (1.5 · 10 5 ) cells were plated in 24-well culture plate (Becton Dickinson, San Jose, CA) 24 h before transfection. GFP-fusion protein expression clones (250 ng) were used for the transfection per well. Cell extracts were prepared 48 h after the transfection by washing cells with PBS and dissolving with 50 ml of the 2· SDS sample buffer [100 mM Tris-Cl (pH 6.8), 4% SDS, 20% glycerol, 0.1% BPB]. After brief sonication, 2-mercaptoethanol was added to the samples to a final concentration of 144 mM and the samples were heated at 95 C for 5 min. The sample (1-5 ml) was applied for SDS-Polyacrylamide gel electrophoresis (SDS-PAGE) (MDG-267 Real Gel Plate, concentration gradient: 5-10%, BIOCRAFT, Japan). At a time, some expression clones were subjected to an in vitro transcription/ translation system according to the above-described method except a labeling using FluoroTectÔ Green Lys tRNA and 5 ml of the sample was used for SDS-PAGE. After the electrophoresis, gels were immersed into the transfer buffer [25 mM Tris-Cl (pH 8.3), 192 mM glycine, 20% (v/v) methanol] for 15 min and the separated proteins were electrophoretically transferred onto PVDF membrane (FluoroTrans W, Pall, USA) using the transfer buffer with the BIOCRAFT BE-300 semidry transfer device. Detection of GFP-fusion protein was performed at room temperature as follows. The transfer membrane was washed with TBS [20 mM Tris-Cl (pH 7.5) and 150 mM NaCl] including 0.05% Tween-20 (TBST) buffer with gentle agitation for 10 min followed by incubation with blocking solution (TBST containing 5% skim milk) for 60 min. The membrane was then incubated with 1:1000 anti-GFP mouse IgG1-k antibody (Nacalai Tesque, Japan) in blocking solution for 60 min. After washing with TBST for 5 min four times, the membrane was incubated with 1:4000 horseradishperoxidase (HRP)-conjugated anti-mouse IgG antibody (Dako Corporation, Carpinteria, CA) in blocking solution for 60 min. GFP-fusion proteins on the membrane were finally detected by ECL plus (Amersham Biosciences, UK) according to the instructions provided by the manufacturer after washing the membrane with TBST for 5 min four times and exposing it to Biomax X-ray films (Kodak, USA) or recording by Luminescent Image Analyzer LAS1000 (FUJIFILM, Japan). Prestained protein size markers (Magic Mark XP, Invitrogen, USA) were used for estimation of the apparent molecular masses of the GFP-fusion proteins.
Results
Cloning of ORFs by homologous recombination
in E. coli In conventional ORF cloning, PCR has been extensively used as a convenient method for excising ORF from parental cDNA clones. Although care was taken to minimize artificial introduction of mutations in ORF during PCR, accidental isolation of artificially mutated clones was always a possibility. This risk obviously increases as the size of ORF increases. Thus, we were strongly motivated to develop an alternative way to isolate ORF clones, because our ORFs of interest were considerably longer than those manipulated in previous reports. [1] [2] [3] [4] 6 In this study, we used a homologous recombination system in E. coli, JC8679, which has genotype of recBC and sbcA, [27] [28] [29] for ORF cloning. This recombination cloning system enabled us to construct multiple clones harboring only ORFs (in practice, from the initiation codon to the termination codon) in parallel through the following three major steps: (i) generation of genespecific trap vector fragments by PCR using pairs of genespecific primers and pTRAP1 plasmid DNA as a template; (ii) transformation of E. coli JC8679 cells with a gene-specific trap vector fragment and a plasmid DNA harboring the ORF of interest by electroporation; (iii) clone selection/confirmation by single-pass sequencing after growth on agar plates containing appropriate antibiotics. An outline of the ORF trap cloning method is schematically shown in Fig. 1A . In brief, pTRAP1 vector was amplified by PCR using the orfn and orfc primers, which contained gene-specific sequences corresponding to a 41-nt anti-sense sequence after the start codon of ORFs and a 42-nt sense sequence before the stop codon of ORFs, respectively, which serve as tags of homologous recombination. The gene-specific sequence of orfn was flanked by the Shine-Dalgarno (SD)-Kozak sequence while orfc was a mixture of oligomers carrying the gene-specific sequence followed by a termination codon and a non-termination codon. The structures of orfn and orfc primers are shown in Fig. 1B . Resultant linear trap-vector fragments, which have gene-specific sequences at the extremities, were cointroduced into E. coli JC8679 cells with the corresponding cDNA clones. From clones appearing on agar plates containing antibiotics, the flanking sequences of the recombination sites of multiple independent clones were confirmed by single-pass sequencing using vector primers to confirm the recombination at an appropriate site and to remove clones with mutations derived from small amounts of incorrectly synthesized primers and/or PCR errors. Mutations introduced in the vector backbone sequence did not matter because the vector backbone was eventually replaced by the expression vectors. In particular, we designed this cloning method so as to be able to simultaneously obtain ORF clones both for production of C-terminal fusion protein and for native protein. For this purpose, the orfc primer was a mixture of two primers with and without the ORF termination codon. As shown in Fig. 1B , to discriminate native and C-terminal fusion type of expression clones, a unique restriction endonuclease cleavage site was introduced in the fusion type of clone at the region where the termination codon was removed. As a result, any tag sequence of interest can be introduced in the unique restriction cleavage site. For maximum versatility, the resultant ORF clones are in a compatible format with an in vitro lambda phage recombinational cloning system, known as the Gateway system. 30 Once the ORF clones were successfully obtained, we were able to prepare expression plasmids for their native, N-terminal fusion and C-terminal fusion proteins in various expression systems on demand using the Gateway recombination cloning system. Using 1589 putative full-length ORFs (from 1121 human and 468 mouse genes) with an average size of 2.8 kb, we successfully prepared expression plasmids for 1463 native proteins and for 1343 fusion proteins by this method. Unlike PCR, homologous recombination-based cloning systems are not expected to introduce point mutations easily because the cloned sequence is amplified in vivo by the endogenous E. coli replication machinery. 31 In fact, the sequencing analysis of coding regions derived from 14 cDNA clones, which totaled $50 kb, revealed no nucleotide substitutions, insertions or deletions after homologous recombination-based cloning (data not shown).
Evaluation of recombinant proteins produced
in vitro by SDS-PAGE To characterize the recombinant proteins, 1530 native type and 1442 GFP-fusion proteins were synthesized in vitro and evaluated by SDS-PAGE. Although some protein products migrated faster or slower than expected, apparent molecular mass estimated by SDS-PAGE is known to vary considerably according to the amino acid sequences and/or post-translational modifications on proteins. 32 Thus, we focused our efforts on comparing the size-differences between the native and the fusion protein to evaluate the recombinant products, rather than on their absolute apparent molecular masses. Thus, apparent molecular masses of 1334 (87%) native recombinant proteins and 1283 (89%) GFP-fusion proteins were estimated in a range from 70 to 160% against molecular weights predicted by SDS-PAGE (Supplementary Table is available at www.dnares. oxfordjournals.org). Fig. 2A shows examples of the analysis of the fluorescence-labeled proteins (clones described in ORFT16 and ORFT17 plates in the Supplementary Table which is available at www.dnares.oxfordjournals. org). Although some small bands, probably resulting from degradation or accidental translation from an internal methionine codon, were seen in some lanes, the sizes of the largest proteins were always compared with the predicted molecular masses. Comparison of the apparent molecular masses of 1179 pairs of native and GFPfusion proteins are shown in Fig. 2B . The average size of fluorescence-labeled native proteins was 111 kDa and the average size-difference between native and GFP-fusion proteins was 29.6 kDa with a standard deviation of 5.3. Because fusion of the GFP moiety resulted in an increase in the molecular mass of the recombinant proteins by 26.8 kDa, the increase of apparent molecular mass of the GFP-fusion protein by $30 kDa on SDS-PAGE indicated that the reading frame of the recombinant protein was correctly maintained after the ORF trap cloning.
Analysis of transiently expressed GFP-fusion proteins in cultured cells
To demonstrate the usefulness of the set of long ORF clones, we first examined the subcellular localization of transiently expressed GFP-fusion proteins in living HEK293 cells along with the systematic analysis for subcellular localization of expressed fusion proteins developed by Simpson and coworkers. 8 Example of subcellular localizations of transiently expressed GFPfusion proteins were shown in Fig. 3A . We identified the subcellular localizations for 719 GFP-fusion proteins in HEK293 cells with a success rate of 82%, and they were tentatively classified into 13 groups as shown in Table 1 . Nearly 34% of the fusion proteins were dispersed in whole cytoplasm, while some proteins were localized in unspecified organelles within the cytoplasm in a speckled distribution (the 'cytoplasmic organelle' group in Table 1 ). Some speckles had the potential to translocate with detectable speed in the cytoplasm, suggesting that their organization is dependent on a microtubular system similar to that of peroxisomes (data not shown). 33 The next most frequently observed localization was the nucleus (12.6%). Although some fusion proteins were localized as interchromatin granule clusters in the nucleus (the 'nuclear vesicle' group in Table 1 ), their detailed localization has yet to be studied. The fluorescent images of HEK293 cells expressing GFP-fusion proteins are accessible through the InGaP database (http://www. kazusa.or.jp/ingap). 34 To confirm biochemically whether exogenous gene products were produced in HEK293 cells, we next analyzed the GFP-fusion proteins transiently expressed in HEK293 cells by protein blot analysis using an anti-GFP antibody. The production levels of the GFP-fusion proteins varied considerably from gene to gene, although all of them were placed under the control of an identical CMV promoter (Fig. 3B, lanes 1-12) . Among 12 GFP-fusion proteins examined in our study, some of them showed the extra bands that were slower to migrate on the SDS-PAGE (white closing brackets in Fig. 3B, lanes 1, 4-7 ) than expected bands with the sizes estimated by in vitro products. Multiple bands that were faster to migrate on the gel were also detected in some lanes. To compare the apparent molecular masses of the recombinant proteins with the extra bands in HEK293 cells that migrated slowly (Cell Ext. in Fig. 3C ) with those of the corresponding in vitro products, the GFP-fusion proteins produced in a rabbit reticulocyte lysate (RRL in Fig. 3C) were simultaneously analyzed by the protein blot analysis using an anti-GFP antibody. The positions of their major products produced in rabbit reticulocyte lysate are indicated by black arrows in Fig. 3C . These results can reveal the occurrence of post-translational events such as modification or processing on certain proteins in certain cells. In the human L1 cell adhesion molecule (L1CAM), the size difference appeared to be caused by protein modifications such as glycosylation because this gene encoded an integral membrane glycoprotein in the immunoglobulin superfamily (Fig. 3C, lane 1) . KIAA1044, KIAA1158, KIAA1169 and KIAA0659 GFP-fusion proteins, which are potassium channel KV4.2, sodium channel beta-3 subunit precursor, twopore channel 1 and neural stem cell-derived dendrite regulator, respectively, also showed distinct SDS-PAGE patterns when they were produced in vivo and in vitro (Fig. 3C, lanes 4-7) .
Discussion
It is widely accepted that full-length cDNA clones in an expression-ready form are essential for functional analysis of mammalian genes. 35 For comprehensive functional analysis, it is an urgent task to prepare a complete set of full-length genes, which can direct the synthesis of authentic proteins encoded by the genome, because they serve as indispensable and versatile reagents for production of recombinant proteins. In mammalian systems, cDNA clones are extensively used for this purpose. There are many sophisticated methods for constructing fulllength clone-enriched cDNA libraries, but none of them guarantees that every cDNA clone thus generated is fulllength. 36, 37 Therefore, the cDNA clones must be carefully evaluated by multiple independent criteria to ensure they are full-length. Since sequence information of orthologous genes among different mammals has become available recently, comparison of the genomic structures of these orthologues enables us to judge whether a cDNA clone encodes full-length ORF or not with increased confidence. The long cDNA clones manipulated in the present study were considered as full-length in this way. 21 Recent technical improvements in comprehensively assigning 5 0 -extreme sequences could eventually confirm the 5 0 -end structures of human cDNAs, [38] [39] [40] and, if necessary, these ORF clones should be revised accordingly. This is highly critical in ORF clones because even a single amino acid change could have a dramatic effect on protein function.
Large cDNAs are generally difficult targets to manipulate, particularly in a systematic manner. Although PCR is often used for ORF cloning of short cDNAs, we considered that for long cDNAs, the amplification step of PCR should be avoided if possible. We developed a homologous recombination system in E. coli to clone large ORF regions into a vector to prevent mutations in the proteincoding sequences in this study. So far, we have attempted to construct 1121 clones for human genes and 468 clones for mouse genes including KIAA and mKIAA genes, which encode relatively large proteins. Most of the clones were confirmed by single-pass sequencing of recombination sites and by evaluation of their expressed proteins. Our experience indicates that this method is quite useful for ORFeome cloning in general.
When considering the role of gene products, it is useful to elucidate their subcellular distribution even though this information is often obtained from experiments using exogenous gene products. According to the UniProt Knowledgebase (http://www.uniprot.org), there are only $80 reports concerning subcellular localizations of KIAA genes in the citation information of the databases. Determination of the subcellular localization of the remaining unanalyzed KIAA gene products is urgently needed. We have been analyzing the subcellular localizations and the records will be available through our InGaP database (http://www.kazusa.or.jp/ingap). 34 This database also contains immunohistochemical data using antibodies against mKIAA proteins, which we accumulated in another project. 24 The comparison of subcellular localizations of mKIAA-GFP fused proteins and antibody-detected mKIAA proteins would provide many biological insights regarding the functions of mKIAA proteins. It should be noted that we analyzed 12 GFP-fusion proteins by protein blotting in parallel with fluorescent imaging analysis. Since we accumulated SDS-PAGE patterns for respective GFP-fusion proteins produced in vitro as described in this study, the comparison of SDS-PAGE patterns for transiently expressed GFP-fusion proteins in certain cells with those of the corresponding in vitro products could reveal occurrence of post-translational modifications (e.g. processing by protease, glycosylation and phosphorylation). Together with the information about their subcellular distribution, these sources of information may provide comprehensive insights into the biological function of KIAA/mKIAA proteins.
According to the Ensembl database (build34, http:// www.ensembl.org), 9.5% of human genes (2108 genes) encode proteins composed of !1000 amino acid residues. While each cDNA is not always full-length, $70% of the entirely sequenced cDNAs corresponding to those genes that encode large proteins (most of which are derived from the human brain) are collected at present in our Institute. 6 as other fulllength cDNA clones, based on structural comparison by FASTA analysis (ungapped identities and coverage against amino acid sequences of KIAA proteins were >95% and >90%, respectively, data not shown). This implies that availability of ORF clones for large proteins is quite low in the research community. As a research group making efforts to identify unknown large cDNAs, we intend to collect as many as possible cDNAs encoding relatively large proteins in a full-length expression-ready form. The collection of mammalian long ORF clones will keep growing and will be an invaluable resource for the advancement of molecular biology and medical science.
